Movements

Biocon Ltd. has appointed MB Chinappa as chief financial officer (CFO) of its subsidiary Biocon Biologics India Ltd. Chinappa joins Biocon Biologics from Biocon’s subsidiary company, Syngene International Ltd., where he was president (Finance) and CFO since 2008.

Novo Nordisk has appointed Vikrant Shrotriya as managing director and corporate vice president for India business. Vikrant was recently working in the GCC (Gulf Cooperation Council) countries wherein he was vice-president for company’s GCC business and corporate vice president for Saudi Arabia.

MSD has appointed Rehan A Khan as managing director for the India region. Khan’s appointment comes over four months after MSD’s previous MD Vivek Vasudev Kamath left the organization after about two years. Incidentally, Khan had resigned from Abbott India in early 2016 after about four years as MD.

The board of directors of Strides Pharma Science Limited has appointed Dr R Ananthanarayanan as chief executive officer (CEO) and managing director of Strides. Dr Ananthanarayanan will succeed Arun Kumar, founder, and the incumbent CEO and MD of the company.

Lupin has appointed J. Alan Butcher as chief corporate development officer. Alan will lead Lupin’s global corporate development efforts and will be responsible for the company’s Global M&A, business development, and licensing functions. In this role, Alan will be responsible for leading the company’s overall business development efforts, with a focus on continuing to build Lupin’s specialty and novel products business.